To the editor:
To the editor:
We thank Zheng et al. for their interest in our meta-analysis of perioperative and long-term outcomes in patients receiving statin therapy before carotid endarterectomy, and their comments regarding the profound academic importance of the study [5] . We agree with Zheng et al. that there may be some degree of heterogeneity (I 2 = 53%; P > 0.06) found in our meta-analysis of perioperative stroke events, as highlighted in our limitations. However, heterogeneity, when detected using the chi-squared (χ 2 ) and I 2 test statistics, is considered to be present when both the χ 2 value is within 5% level of significance p < 0.050 and the I 2 value exceeds 33% [4] . In the metaanalysis of perioperative stroke events, heterogeneity was detected with the I 2 test. However, the χ 2 test did not reveal significant heterogeneity. Therefore, conclusions by Zheng et al. in regard to the presence of considerable heterogeneity and lack of reliability in the pooled results may be over-stated.
In the meta-analysis of perioperative stroke events, random effects models were utilized. This is a well-established and appropriate statistical method for pooling heterogeneous results [1, 2] . Zheng et al. have attempted to address the presence of heterogeneity by performing an additional sensitivity analysis. The authors describe the removal of a single study from the pooled results but do not provide a rationale for the study selection. The Cochrane handbook, which the authors have referenced, details the methodology for a sensitivity analysis [3] . However, it does not provide evidence to suggest that heterogeneity adjustment is an appropriate indication for its use [3] . Therefore, we do not consider the sensitivity analysis by Zheng et al. to provide additional value to the results of our study.
In light of the heterogeneity present among the included studies, the meta-analysis should be interpreted with caution. The results have suggested that administration of statin therapy before carotid endarterectomy is associated with lower rates of perioperative stroke. Therefore, future investigation to characterize the degree and nature of the potential benefit of statin therapy on perioperative outcomes among patients undergoing carotid endarterectomy for internal carotid artery stenosis is warranted.
